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Chemokines: A New Classification Review
System and Their Role in Immunity
the same molecule under different names. This has led
to significant confusion, even among scientists actively
working in the field. To address this issue, the classifica-
Albert Zlotnik*³ and Osamu Yoshie²³
*DNAX Research Institute
Palo Alto, California 94304
tion system presented in Table 1 was presented at theDepartment of Bacteriology
last Keystone Chemokine Symposium. Chemokines²Kinki University School of Medicine
have been divided into the two major subfamilies on theOsaka-Sayama 589-8511
basis of the arrangement of the two N-terminal cysteineJapan
residues, CXC and CC, depending on whether the first
two cysteine residues have an amino acid between them
Chemokines are a group of small (z8±14 kDa), mostly (CXC) or are adjacent (CC). The genes for these families
basic, structurally related molecules that regulate cell are currently designated SCY (small secreted cytokine)
trafficking of various types of leukocytes through inter- with SCYa corresponding to the CC subfamily and SCYb
actions with a subset of seven-transmembrane, G pro- to the CXC subfamily. Two other classes of chemokines
tein±coupled receptors. About 40 chemokines have now have been described: lymphotactin (C or SCYc) and
been identified in humans. They mainly act on neutro- fractalkine (CX3C or SCYd). The former one lacks cyste-
phils, monocytes, lymphocytes, and eosinophils and ines one and three of the typical chemokine structure
play a pivotal role in host defense mechanisms. The (Kelner et al., 1994), while the latter one exhibits three
study of chemokines has recently overlapped more with amino acids between the first two cysteines and is also
other fields of immunology. It has now become evident the only membrane-bound chemokine through a mucin-
that chemokines play fundamental roles in the develop- like stalk (Bazan et al., 1997). The proposed chemokine
ment, homeostasis, and function of the immune system. nomenclature is based on the chemokine receptor no-
The rapid increase in the number of chemokines along menclature currently in use, which uses CC, CXC, XC,
with other complex issues described below have led to or CX3C followed by R (for receptor) and then a number.
a situation where a newcomer attempting to understand Thus, we have CCR1±9, CXCR1±5, XCR1 (the lympho-
this field faces a daunting task. In this review, our goal tactin receptor), and CX3CR1 (the fractalkine receptor).
is to present a concise overview of the chemokine super- Basically, the new nomenclature replaces R with L (li-
family. The chemokines have a wide range of effects in gand instead of receptor) to designate the ligands and
many different cell types beyond the immune system, uses CC for the SCYa family, CXC for SCYb, XC for
including, for example, various cells of the central ner- SCYc, and CX3C for SCYd. The numbering system is
vous system (Ma et al., 1998) or endothelial cells, where the one already in use to designate the genes encoding
they result in either angiogenic or angiostatic effects each chemokine. Thus, a given gene will have the same
(Strieter et al., 1995). However, the scope of this review number as its protein ligand (for example, ScyA 27 is
makes it difficult to provide a comprehensive view of the gene encoding CCL27), a correlation that should
such a complex and expanding field. For this reason, further simplify matters. Besides eliminating ambigu-
we will focus on several areas of chemokine biology of ities, the new nomenclature directly indicates the class
particular interest to immunologists. to which each chemokine belongs.
The development of EST (expressed sequence tag) For many immunologists, it is important to know the
databases and bioinformatics (computer-assisted se- mouse chemokines. The new nomenclature system,
quence analysis) have allowed the rapid identification however, is currently focused on the human chemokines
of novel genes. The chemokines have been particularly as ªstandard.º The chemokines described in other spe-
well suited for these techniques since they represent cies can be grouped into four categories. (1) Chemo-
very abundant messages in those cells that express kines that unambiguously (based on a high degree of
them. Since they are small proteins, the probability that sequence homology, and chromosomal location to
their entire coding regions were represented as ESTs in syntenic regions between species) correspond to a
databases was very high. As a result, the chemokines given human ligand; examples include CCL5/RANTES,
have been one of the first molecular families to experi- CCL17/TARC, CCL25/TECK, etc. (2) Chemokines re-
ence the full impact of genomics and bioinformatics, to lated to a human homolog but whose exact homolog is
the point that it is very likely that most of them have not certain (indicated by a question mark in Table 1).
Examples of this category include the monocyte chemo-now been discovered. This allows us to take a global
tactic proteins CCL2/MCP-1, CCL7/MCP-2, CCL8/MCP-3,perspective of the field for useful lessons that we may
and CCL13/MCP-4, etc., of which there are currentlybe able to apply to other molecular families in the future.
four described in human and four in mouse (one of the
latter present only in GenBank). Currently, because ofProposed New Classification
their close sequence similarity, it is not possible to un-for Chemokine Ligands
ambiguously determine which mouse ligand corre-Table 1 shows the known human chemokines. One prob-
sponds to which human ligand. Another example islem the field faced following the rapid pace of new che-
CCL15/HCC2/leukotactin/MIP1d, which could repre-mokine discovery is that several groups often reported
sent the human counterpart of either mouse C10 or
mouse CCF18/mMRP2/MIP1g. (3) Those chemokines³ To whom correspondence should be addressed (e-mail: zlotnik@
dnax.org and o.yoshie@med.kindai.ac.jp). for which no human counterpart has been described yet
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Table 1. CXC, C and, CX3C Chemokine/Receptor Families
CXC Chemokine/Receptor Family
Systematic Name Human Chromosome Human Ligand Mouse Ligand Chemokine Receptor(s)
CXCL1 4q12-q13 GROa/MGSA-a GRO/KC? CXCR2 . CXCR1
CXCL2 4q12-q13 GROb/MGSA-b GRO/KC? CXCR2
CXCL3 4q12-q13 GROg/MGSA-g GRO/KC? CXCR2
CXCL4 4q12-q13 PF4 PF4 Unknown
CXCL5 4q12-q13 ENA-78 LIX? CXCR2
CXCL6 4q12-q13 GCP-2 CKa-3 CXCR1, CXCR2
CXCL7 4q12-q13 NAP-2 Unknown CXCR2
CXCL8 4q12-q13 IL-8 Unknown CXCR1, CXCR2
CXCL9 4q21.21 Mig Mig CXCR3
CXCL10 4q21.21 IP-10 IP-10 CXCR3
CXCL11 4q21.21 I-TAC Unknown CXCR3
CXCL12 10q11.1 SDF-1a/b SDF-1 CXCR4
CXCL13 4q21 BLC/BCA-1 BLC/BCA-1 CXCR5
CXCL14 Unknown BRAK/bolekine BRAK Unknown
(CXCL15) Unknown Unknown Lungkine Unknown
C Chemokine/Receptor Family
Systematic Name Human Chromosome Human Ligand Mouse Ligand Chemokine Receptor(s)
XCL1 1q23 Lymphotactin/SCM-1a/ATAC Lymphotactin XCR1
XCL2 1q23 SCM-1b Unknown XCR1
CX3C Chemokine/Receptor Family
Systematic Name Human Chromosome Human Ligand Mouse Ligand Chemokine Receptor(s)
CX3CL1 16q13 Fractalkine Neurotactin CX3CR1
CC Chemokine/Receptor Family
Systematic Name Human Chromosome Human Ligand Mouse Ligand Chemokine Receptor(s)
CCL1 17q11.2 I-309 TCA-3, P500 CCR8
CCL2 17q11.2 MCP-1/MCAF JE? CCR2
CCL3 17q11.2 MIP-1a/LD78a MIP-1a CCR1, CCR5
CCL4 17q11.2 MIP-1b MIP-1b CCR5
CCL5 17q11.2 RANTES RANTES CCR1, CCR3, CCR5
(CCL6) Unknown C10, MRP-1 Unknown
CCL7 17q11.2 MCP-3 MARC? CCR1, CCR2, CCR3
CCL8 17q11.2 MCP-2 MCP-2? CCR3
(CCL9/10) Unknown MRP-2, CCF18 MIP-1g Unknown
CCL11 17q11.2 Eotaxin Eotaxin CCR3
(CCL12) Unknown MCP-5 CCR2
CCL13 17q11.2 MCP-4 Unknown CCR2, CCR3
CCL14 17q11.2 HCC-1 Unknown CCR1
CCL15 17q11.2 HCC-2/Lkn-1/MIP-1d Unknown CCR1, CCR3
CCL16 17q11.2 HCC-4/LEC LCC-1 CCR1
CCL17 16q13 TARC TARC CCR4
CCL18 17q11.2 DC-CK1/PARC AMAC-1 Unknown Unknown
CCL19 9p13 MIP-3b/ELC/exodus-3 MIP-3b/ELC/exodus-3 CCR7
CCL20 2q33-q37 MIP-3a/LARC/exodus-1 MIP-3a/LARC/exodus-1 CCR6
CCL21 9p13 6Ckine/SLC/exodus-2 6Ckine/SLC/exodus-2/TCA-4 CCR7
CCL22 16q13 MDC/STCP-1 ABCD-1 CCR4
CCL23 17q11.2 MPIF-1 Unknown CCR1
CCL24 7q11.23 MPIF-2/Eotaxin-2 Unknown CCR3
CCL25 19p13.2 TECK TECK CCR9
CCL26 7q11.23 Eotaxin-3 Unknown CCR3
CCL27 9p13 CTACK/ILC ALP/CTACK/ILC ESkine CCR10*
*We recently identified the receptor for CCL27, which has been named CCR10 (Homey et al., 2000).
While we have tried to include most of the names with which a particular chemokine has been described, we may have missed some; for
this we apologize in advance. We have also tried to list the main receptors for each chemokine, although some may bind other receptors but
may not be their primary ligands. A question mark indicates that the listed mouse homolog may not correspond to the listed human ligand
(see text). A systematic name in parenthesis indicates that the human homolog has not yet been identified.
This provisional nomenclature proposal has been submitted to the International Union of Immunological Societies (IUIS) Subcommittee on
Chemokine Nomenclature (chairman, R. Thorpe) for consideration as an internationally approved nomenclature.
(e.g., CXCL15/lungkine [Rossi et al., 1999]). Yet another looking at a molecular family globally is that we get
closer to answering the question of how applicable arecategory includes (4) human chemokines for which no
mouse chemokine has been described (e.g., CXCL8/IL-8, findings in mouse models to humans? The answer is
that, to date, most chemokines have a correspondingCCL18/DC-CK-1/PARC). Thus, another advantage of
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human ligand, but not all. This is a situation that will no Besides accounting for a fresh perspective of the che-
mokine superfamily, this model has important implica-doubt apply to many other molecular families.
However, the differences between the mouse and hu- tions for other gene families. The chemokine superfamily
represents an example of the forces that shape evolutionman chemokines not only reflect evolutionary patterns
within this gene superfamily but also offer clues to un- at the molecular level, which are a reflection of the func-
tion(s) of the genes involved.derstanding their biological functions. Most, if not all,
chemokines probably arose from gene duplication from The biologic effects of the chemokines are mediated
by seven-transmembrane-domain receptors that repre-a single ancestral gene. Many chemokines are clustered
in certain chromosomal locations (Table 1). Two main sent a subset of the G protein±coupled receptor (GPCR)
superfamily. Most of them also exist in clusters thatclusters have been recognized. Many human CXC che-
mokines that mainly act on neutrophils are clustered at are located on chromosomes 2 and 3. At present, 16
receptors have been identified. Table 1 summarizes thechromosome 4q12±13, while many CC chemokines that
mainly act on monocytes are located in another cluster correspondence between human chemokine ligands
and human chemokine receptors. This table also showsat 17q11.2. However, the genes of the more recently
discovered CC and CXC chemokines, which act mainly redundancy and binding promiscuity between many li-
gands and receptors. This promiscuity is real becauseon lymphocytes, tend to be located elsewhere in new
chromosomal locations away from the major clusters it involves high-affinity interactions. Thus, a single che-
mokine may bind to several receptors, whereas a single(Table 1). Interestingly, several chromosome 4 CXC
chemokines that turned out to be highly specific for chemokine receptor may transduce signals for several
chemokines. This is one of the most intriguing featuresT lymphocytes (i.e., CXCL9/MIG, CXCL10/IP-10, and
CXCL11/I-TAC) are also located in a minicluster sepa- of the chemokine superfamily and may reflect their abil-
ity to regulate many different leukocyte subpopulations,rate from the major CXC cluster located in chromosome
4q12-q13. This diversification likely reflects functional especially in complex microenvironments such as acute
or chronic inflammatory responses. However, as we ex-specialization that has developed during the evolution
of this superfamily and suggests that those chemokines plained above, this is more common among the ªclusterº
chemokines than among those located in isolated chro-located in different chromosomal locations from the ma-
jor clusters are probably older in evolutionary terms and mosomal locations. Nevertheless, as we will see below,
functional redundancy is not likely to be the rule in thehave remained more conserved between species be-
cause of their highly specific functions. They are also chemokine superfamily. Rather, chemokines, especially
the most recently discovered members of the superfam-less likely to share receptors or overlap functions with
other chemokines. In contrast, the major cluster chemo- ily, can exhibit high tissue and receptor specificity. Other
chemokines play a pivotal role in homeostasis as wellkines (4q12±13 and 17q11.2) are likely to have been
generated more recently in evolutionary terms. The fact as in inflammatory responses that cannot be replaced
with other chemokines.that the genes encoding these chemokines were al-
lowed by evolution to duplicate rapidly and form a clus- We will use as examples several areas of interest to
immunologists, including lymphoid development, den-ter suggests that their functions remained to a certain
extent related. This would explain why they share recep- dritic cells and the initiation of immune responses, and
the Th1 and Th2 paradigm. We will describe a model oftors extensively, do not exactly correspond genetically
and functionally between mice and humans, and tend chemokine function that should clarify the function of
chemokines in these areas and the implications of thisto act on the same leukocytes, neutrophils and mono-
cytes. The multiplication of these ªclusterº chemokines model for the role of chemokines in the immune system.
probably stems more from the quantitative need to
produce a chemoattractant for either neutrophils or Chemokines and Dendritic Cells
One of the most interesting recent developments in che-monocytes during inflammatory responses. Interestingly,
some of these chemokines can exhibit relatively high mokine biology has been the association between che-
mokines and dendritic cells. Dendritic cells produce sev-specificity depending on the producing cell type (i.e.,
each cell type may produce its own version of chemoat- eral chemokines, some of them in a highly specific
manner. These include, for example, CCL17/TARC (Imaitractants for either neutrophils or monocytes). This pro-
duction pattern probably reflects the different anatomi- et al., 1996; Sallusto et al., 1999a), CCL18/DC-CK-1/
PARC (Adema et al., 1997; Hieshima et al., 1997; Sallustocal sites where each producing cell is located. Therefore,
the functional specificities may be less important for et al., 1999a), CCL25/TECK (Vicari et al., 1997), CCL22/
MDC (Godiska et al., 1997; Sallusto et al., 1999a), andthis type of chemokine; their main function is likely to
be the attraction of neutrophils or monocytes, while their CCL19/MIP3b/ELC (Ngo et al., 1998; Sallusto et al.,
1999a). Of these, probably the most dendritic specificspecificity may be a secondary issue. In a sense they
may be redundant, but they are nevertheless needed is CCL17, which along with CCL22 signals through CCR4
(Imai et al., 1999). In turn, this receptor has been associ-for the overall robust recruitment of these types of leuko-
cytes. Therefore, one key concept in order to understand ated with the Th2 phenotype (see below). In any case,
these observations strongly suggest a role for chemo-the physiology of the chemokine superfamily is to view
these chemokine clusters as single entities based on kines in the initiation of immune responses and more
specifically suggest that some chemokines may havetheir overall function. If we view the chemokine super-
family as a group of noncluster chemokines plus the adjuvant properties. The current data strongly suggests
that dendritic cells can recruit various T cell subsetstwo main clusters, we can conclude that there is little
redundancy and good correlation between the functions through their specific production of various chemokines.
The chemokine receptors also exhibit strong specific-of the human chemokines and those of other mammalian
species. ity for dendritic cell subsets. Immature dendritic cells
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have been shown to express CCR6 and respond to rearrangement, b selection, and positive or negative se-
lection). The current available information on CXCR4,CCL20/MIP3a/LARC in vitro (Dieu et al., 1998). Once
these cells pick up antigen, they start to mature and to CCR5, or CCR8 expression on thymocytes suggests
that this is the case (Zaitseva et al., 1998; Zingoni et al.,express CCR7 (Sallusto et al., 1998), which has recently
been shown to be pivotal for their migration to the lymph 1998). The recent data showing that immature thymo-
cytes respond to CCL25 also suggests that CCR9 ex-nodes (FoÈ rster et al., 1999). Dendritic cells can then
respond to CCL19/MIP3b/ELC and CCL21/6Ckine/SLC, pression will define discrete thymocyte subsets. This
model explains the relocation of different thymocytewhich allows them to migrate to the local draining lymph
nodes, where they will be able to activate more antigen- subsets to specific areas of the thymus, depending on
their maturational status, and also suggests that thespecific T cells (Kellermann et al., 1999). These studies
and others (Adema et al., 1997; Ngo et al., 1998; Gunn expression of chemokine receptors will define functional
subpopulations of thymocytes. Viewed from this per-et al., 1999; Sallusto et al., 1999a) strongly suggest that
the production of chemokines by dendritic cells is not spective, chemokines can prove to be extremely impor-
tant in lymphopoiesis. Another open question from thisa random event, but rather a specific phenomenon that
deserves further study to establish their function during model is whether chemokines act only to direct the mi-
gration of specific thymocyte subsets or whether theyimmune responses.
Another area where dendritic cells currently are being also have direct differentiation effects on the developing
thymocytes. Clearly, this is a very interesting area forstudied is for their role as potentiators of immune re-
sponses against tumors. Here, chemokines may also future study.
play an important role. XCL1/lymphotactin-transfected
dendritic cells are better able to induce anti-tumor re- Chemokines and the Lymphoid System
sponses than the corresponding dendritic cells alone Chemokines can be divided into two categories: homeo-
(Cao et al., 1998). For recent reviews on chemokines static and inflammatory. The former are those constitu-
and tumors see Arenberg et al., 1997, and Wang et al., tively expressed in a certain tissue or organ, suggesting
1998. a specific function involving cell migration. The inflam-
matory chemokines in contrast are strongly upregulated
by inflammatory or immune stimuli in various cell typesChemokines and Lymphocyte Development
A few years ago, nothing was known about a potential (macrophages, fibroblasts, T cells, etc.). The latter are
likely to participate in the development of immune orrole of chemokines in lymphoid development. However,
now there are several examples of chemokines involved inflammatory reactions. Recently, a dramatic example
of a homeostatic chemokine has been described. It in-in both B and T cell development. For example, the
CXCL12/SDF-12/2 mouse dies perinatally and has a volves the analysis of a spontaneous mouse mutant
designated plt (paucity of lymph node T cells) (Nakanodefect in B cell lymphopoiesis (Nagasawa et al., 1996).
The defect may be due to defects in the bone marrow et al., 1998). This mutation was recognized because the
mice showed a severe depletion of lymph node T cells.stromal microenvironment, which looks disorganized.
The CXCR42/2 mouse also shows similar defects, sug- This defect appeared to be due to failure to express a
chemokine (CCL21/6ckine/SLC) (Gunn et al., 1999). Onegesting that the only ligand of CXCR4 is CXCL12 (Ma
et al., 1998; Tachibana et al., 1998; Zou et al., 1998). of the names under which CCL21 was originally de-
scribed was SLC (Table 1), which stands for ªsecondaryChemokines may also be important in the thymic micro-
environment. Several chemokines have been reported lymphoid organ chemokineº and reflected its strong ex-
pression in lymph nodes and other peripheral lymphoidto be expressed during thymic development, including
XCL1/lymphotactin, CCL3/MIP1a, CCL4/MIP1b (Kelner organs (Nagira et al., 1998). It was found to be expressed
by high endothelial venules and lymphatic endothelialand Zlotnik, 1995), CCL17/TARC (Imai et al., 1996),
CCL21/6ckine/SLC (Campbell et al., 1999a), and CCL25/ cells (Gunn et al., 1999). While the exact mutation ac-
counting for the plt phenotype is not yet known, thisTECK (Vicari et al., 1997). Expression of the latter one
has only been detected in the thymus, and, to a lesser mouse cannot express CCL21 in the lymph nodes. How-
ever, another recent report showed that there are twoextent, in the small intestine, an organ that is also be-
lieved to be a site of extrathymic development (Vicari forms of mouse CCL21 and that only one (normally ex-
pressed in the lymph nodes) is not expressed in the pltet al., 1997). CCL25 is produced by thymic dendritic cells
(Vicari et al., 1997) as well as epithelial cells (Wilkinson et mouse (Vassileva et al., 1999). The current information
suggests the following model: one of the forms of CCL21al., 1999). Recently, its receptor has been identified as
the previously orphan receptor GPR9-6 and was there- is necessary for the migration of many T cells to the
lymph nodes. This likely occurs through its interactionfore renamed CCR9 (Zaballos et al., 1999). Furthermore,
it has been shown that immature thymocytes respond with CCR7, a receptor known to be expressed in naive
T cells (Yoshida et al., 1997). We would therefore predictto CCL25, suggesting that CCL25 may be particularly
important in early thymic development (Campbell et al., that a CCR72/2 mouse would have a phenotype similar
to the plt mouse (deficiency in number of lymph node1999a). This differential responsiveness of thymocytes
to chemokines indicates that thymocytes at different T cells), a prediction confirmed by a very recent study
(FoÈ rster et al., 1999). Interestingly, three chemokines arestages of development express different chemokine re-
ceptors. In turn, the signals that regulate the expression capable of binding CCR7 in the mouse: the two forms
of CCL21 (which differ by one amino acid [serine/leu-of these receptors may depend on having each thymo-
cyte achieve specific ªmilestonesº in its development cine] at position 65) and CCL19/MIP3b/ELC. Only CCL21
(serine) is missing in the plt mouse (Vassileva et al.,(commitment to the T cell lineage, ab versus gd TCR
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1999) indicating that while other CCR7 ligands (CCL21/ the Th1 or Th2 phenotype? There is little data on the
latter possibility, although CCL3/MIP1a and CCL2/leucine and CCL19) exist in this mouse, only CCL21/
serine can mediate T cell homing to the lymph nodes. MCP-1 have been described as capable of inducing
the differentiation of Th1 and Th2 T cells (Karpus andThere are two possibilities to explain these results. One
is that the other CCR7 ligands may not be expressed Kennedy, 1997). Studies using the CCL32/2 or CCL22/2
mice will help elucidate how these chemokines partici-in the relevant endothelial cells of the lymph nodes.
Alternatively, each form may deliver a different signal pate in these responses.
Interestingly, CCR4 and CCR8 are strongly upregu-through CCR7 to T cells. This is a topic for future re-
search. lated at the mRNA level in T cell populations polarized
to the Th2 phenotype, but CCR3 mRNA is not abundantIn the case of B cells, there is another example where
chemokines direct the migration of lymphocytes to in these populations (Zingoni et al., 1998; Imai et al.,
1999). However, the latter receptor can be used as alymph nodes. B cells in mice lacking CXCR5 (formerly
BLR-1) do not migrate from the T cell±rich zone into B marker for human T cells that produce IL4, as mentioned
above (Sallusto et al., 1997). This observation suggestscell follicles in the spleen or the Peyer's patches (Forster
et al., 1996). Thus, the ligand for CXCR5, which has that CCR3 may be a marker for a subset of Th2 cells,
while CCR4 and CCR8 may be expressed more widelynow been identified as CXCL13/BLC/BCA-1 (Gunn et al.,
1998; Legler et al., 1998), is essential for B cell migration in Th2 polarized populations. This example leads us to
a model with similarities to the one we described abovewithin specific anatomical compartments in various
lymphoid tissues. in T cell development: the expression of chemokine re-
ceptors may eventually help us to define functional sub-These are examples of both the importance of the
chemokine system in normal hematopoietic cell migra- populations of T cells and other leukocyte subsets that
participate in specific immune responses (Sallusto ettion and of the lack of functional redundancy of the
system. al., 1999b). In fact, once we know all the members of
the chemokine superfamily, we may be able to produceA different example of chemokines directing the mi-
gration of specific cell subsets to specific anatomical ªmapsº of cells participating in a given immune response
as a function of time. For example, specific antigen-sites has recently been reported (Campbell et al., 1999b).
The chemokine CCL17/TARC was shown to recruit CLA1 presenting cells may produce certain chemokines that
chemoattract specific subpopulations, which then dif-T cells (a T cell subset that predominates in the skin) to
the skin. However, this story may be more complicated ferentiate into effector cells. As these cells are differenti-
ating, their expression of chemokine receptors changesthan it appears. We have recently observed that CCL27/
CTACK is also a chemoattractant for some CLA1 T cells and they start migrating. When they arrive at a microen-
vironment where a gradient for a particular chemokine is(Morales et al., 1999). In contrast to CCL17, which is
more widely expressed (probably by dendritic cells), present, they will migrate up this gradient until a certain
concentration of chemokine induces desensitizationCCL27 is specifically expressed in skin, where it is pro-
duced by keratinocytes. Thus, the latter is an example and the cell will then stop. At this point, it may again
change its chemokine receptor expression, for example,of a tissue-specific chemokine that can direct the migra-
tion of a specific cellular subset to an anatomical site. as they encounter their specific antigen on an antigen-
presenting cell, and will now respond to a new chemo-
kine gradient. This model explains the specific locationChemokines and the Th1/Th2 Responses
of particular cellular populations, depending on theirFor many years chemokines coexisted with the Th1/Th2
state of differentiation. The emerging picture of chemo-paradigm without intersecting. This situation changed
kine control of immune responses is consistent with thiswhen a report documented that CCR31 human T cells
model.preferentially produced IL4, suggesting that they had a
Another potentially important area for future researchTh2 phenotype (Sallusto et al., 1997). Following that
is the study of the chemokine production by Th1 andinitial report, a number of chemokine receptor associa-
Th2 cells. Th1 cells have been shown to produce manytions with the Th1 and Th2 phenotypes have been re-
more chemokines than Th2 cells (Bradley et al., 1999).ported (O'Garra et al., 1998). CCR5 and CXCR3 have
Furthermore, the production of some chemokines is in-been associated with the Th1 phenotype, while CCR3,
duced by Th2 cytokines like IL-4 (Orlofsky et al., 1994) orCCR4, and CCR8 have been associated with the Th2
IL-10 (Hedrick et al., 1998). These observations suggestphenotype. Interestingly, the expression of these recep-
that the chemokines may have more influence on thetors may change depending on the activation status of
control of Th1/Th2 responses than we currently under-the T cell. For example, CCR8 is only strongly expressed
stand.in activated Th2 cells (Zingoni et al., 1998). These obser-
vations raise several questions. For example, will the
ligands of each of these receptors preferentially chem- Conclusions
In the last few years, the chemokines have emerged asoattract either the Th1 or Th2 subsets? This has gener-
ally been shown to be the case and suggests that these an important superfamily whose importance extends
far beyond their most famous function as inflammatoryligands participate in the development of either Th1 or
Th2 responses. The presence of these receptors on Th1 mediators. Indeed, they are important molecules not
only in inflammatory responses but also as immunomod-and Th2 cells also raises the question of whether these
ligands only participate in the recruitment of these cells ulators and they also have critical functions in lympho-
poiesis.to sites of developing immune responses, or do they
directly influence the differentiation of naive T cells to One of the lessons that we are trying to convey in
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Campbell, J.J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath,this review is that the traditional view of chemokines
P., Andrew, D.P., Warnke, R., Ruffing, N., Kassam, N., Wu, L., andas chemoattractants may be an oversimplification. We
Butcher, E.C. (1999b). The chemokine receptor CCR4 in vascularshould keep this superfamily in mind, as it is integrated
recognition by cutaneous but not intestinal memory T cells. Nature
in nature with many other mediators to control immune 400, 776±780.
and inflammatory responses. The recent biology of the Cao, X., Zhang, W., He, L., Xie, Z., Ma, S., Tao, Q., Yu, Y., Hamada,
chemokines is very exciting. It opens potential applica- H., and Wang, J. (1998). Lymphotactin gene-modified bone marrow
tions in a number of areas. In the latter respect, the fact dendritic cells act as more potent adjuvants for peptide delivery to
induce specific antitumor immunity. J. Immunol. 161, 6238±6244.that their receptors are G protein±coupled receptors
Dieu, M.C., Vanbervliet, B., Vicari, A., Bridon, J.M., Oldham, E., Ait-makes them ideally suited for the development of small
Yahia, S., Briere, F., Zlotnik, A., Lebecque, S., and Caux, C. (1998).molecule inhibitors with strong therapeutic potential.
Selective recruitment of immature and mature dendritic cells byLooking beyond their biology, the chemokine super-
distinct chemokines expressed in different anatomic sites. J. Exp.
family provides an important example for other molecu- Med. 188, 373±386.
lar families that remain to be discovered and character- Forster, R., Mattis, A.E., Kremmer, E., Wolf, E., Brem, G., and Lipp,
ized. Like the chemokines, some members will be M. (1996). A putative chemokine receptor, BLR1, directs B cell mi-
expressed widely while others will exhibit high tissue gration to defined lymphoid organs and specific anatomic compart-
ments of the spleen. Cell 87, 1037±1047.specificity. Typically, the latter will only be discovered
when the particular tissue in which they are expressed is FoÈ rster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-MuÈ ller, I.,
Wolf, E., and Lipp, M. (1999). CCR7 coordinates the primary immuneanalyzed through an EST sequencing project. We should
response by establishing functional microenvironments in second-then expect that those genes with the highest expres-
ary lymphoid organs. Cell 99, 23±33.sion specificity will be the last ones to be found. Impor-
Godiska, R., Chantry, D., Raport, C.J., Sozzani, S., Allavena, P.,tantly, our global view of chemokine biology proposes
Leviten, D., Mantovani, A., and Gray, P.W. (1997). Human macro-
a link between chromosomal location, gene function, phage-derived chemokine (MDC), a novel chemoattractant for
and molecular evolution. monocytes, monocyte-derived dendritic cells, and natural killer
Other characteristics that may be common to other cells. J. Exp. Med. 185, 1595±1604.
molecular families important in immunology include the Gunn, M.D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Wil-
liams, L.T., and Nakano, H. (1999). Mice lacking expression of sec-dual roles in homeostasis and inflammation. The latter
ondary lymphoid organ chemokine have defects in lymphocyte hom-aspect, after all, is part of the mammalian metabolism,
ing and dendritic cell localization. J. Exp. Med. 189, 451±60.which can alternate between both conditions. We there-
Gunn, M.D., Ngo, V.N., Ansel, K.M., Ekland, E.H., Cyster, J.G., andfore need to be able to explain both the steady state as
Williams, L.T. (1998). A B-cell-homing chemokine made in lymphoidwell as inflammatory conditions. Part of the answer will
follicles activates Burkitt's lymphoma receptor-1. Nature 391,
come from the study of gene expression in various tis- 799±803.
sues as they switch between both states. We predict Hedrick, J.A., Helms, A., Vicari, A., and Zlotnik, A. (1998). Character-
that the regulation of chemokine expression will play an ization of a novel CC chemokine, HCC-4, whose expression is in-
important role in the transition from one state to the creased by interleukin-10. Blood 91, 4242±4247.
other. Hieshima, K., Imai, T., Baba, M., Shoudai, K., Ishizuka, K., Nakagawa,
T., Tsuruta, J., Takeya, M., Sakaki, Y., Takatsuki, K., et al. (1997). AThe past five years have been a very exciting time in
novel human CC chemokine PARC that is most homologous tothe chemokine field. We have witnessed the discovery
macrophage-inflammatory protein-1 alpha/LD78 alpha and chemo-and characterization of many of the chemokines that
tactic for T lymphocytes, but not for monocytes. J. Immunol. 159,
appear in Table 1. Extrapolating the chemokine experi- 1140±1149.
ence of the last few years, we should expect fast prog-
Homey, B., Wang, W., Soto, H., Buchanan, M., Wiesenborn, A.,
ress in many other molecular families. The new technolo- Catron, D., MuÈ ller, A., McClanahan, T., Orozco, R., et al. (2000).
gies of genomics and bioinformatics are about to The orphan chemokine receptor GPR-2 (CCR10) binds the skin-
associated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol., intransform our view of immunology.
press.
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